enzh-TWfrdeitjaptrues

Date: 6/12/2002

Dr. LeBlond's Presentation at 8th International Conference on Malignant Lymphoma in Lugano Switzerland. (Audio Only)

Running Time: 8:49 minutes (Audio Only)
Size: 2.07 MB

Play Audio Clip

Latest Bing Center News

Dr Castillo on the Efficacy of Iopofosine I 131 in Waldenström Macroglobulinemia

Dr Castillo on the Efficacy of Iopofosine I 131 in Waldenström Macroglobulinemia

Jorge J. Castillo, MD, clinical director, Bing Center for Waldenström Macroglobulinemia, institute physician, Dana-Farber Cancer Institute, associate professor, medicine, Harvard Medical School, discusses the efficacy of treatment with iopofosine I 131 (previously CLR 131) in patients with Waldenström macroglobulinemia.

Read more..

Waldenstrom Macroglobulinemia: Who Gets What and When?

Waldenstrom Macroglobulinemia: Who Gets What and When?

As many as 50% of people at the time of their Waldenstrom macroglobulinemia (WM) diagnosis won’t need drug therapy for a number of years. We spoke with Shayna Sarosiek, MD, hematologist/oncologist from at the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, to share what “supportive treatments” could help in the meantime.

Read more..

In Memoriam of Dr. Enrica Morra

In Memoriam of Dr. Enrica Morra

Dear Members of the Waldenstrom’s Macroglobulinemia Community: I wanted to share with you the sad news that our colleague and friend, Dr. Enrica Morra recently passed away. Dr. Morra was the Co-Chair of 6th International Workshop on Waldenstrom’s Macroglobulinemia (IWWM) which was held in Venice, Italy (2010), and a recipient of the Jan Gosta Waldenstrom Award for Lifetime Contributions to Waldenstrom’s Macroglobulinemia at the 8th IWWM in London, UK (2014).

Read more..

ASH-2023 Posters Presented

ASH-2023 Posters Presented

The following posters were presented by the Bing Center at the ASH 2023 meeting, December 9-12, 2023 in San Diego. For more information about the ASH 2023 meeting, please visit https://www.hematology.org/meetings/annual-meeting.

Read more..

ASH 2023 - Bing Center Abstracts to be Presented

ASH 2023 - Bing Center Abstracts to be Presented

The following abstracts represent the research that will be presented by the Bing Center at the ASH 2023 meeting, December 9-12, 2023 in San Diego. For more information about the ASH 2023 meeting, please visit https://www.hematology.org/meetings/annual-meeting.

Read more..

Waldenstrom: Reaching the Relapsed Refractory Stage

Waldenstrom: Reaching the Relapsed Refractory Stage

Waldenstrom Macroglobulinemia (WM) is not curable, which means most patients will either reach the relapsed or refractory stage at some point in their journey. Patient Power spoke with Shayna Sarosiek, MD, hematologist/oncologist from at the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, to share what reaching these stages mean for WM patients.

Read more..

Waldenstrom Macroglobulinemia: Who Gets What and When?

Waldenstrom Macroglobulinemia: Who Gets What and When?

As many as 50% of people at the time of their Waldenstrom macroglobulinemia (WM) diagnosis won’t need drug therapy for a number of years. We spoke with Shayna Sarosiek, MD, hematologist/oncologist from at the Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber Cancer Institute in Boston, to share what “supportive treatments” could help in the meantime.

Read more..

We want YOU to join our Jimmy FundRaiser community!

We want YOU to join our Jimmy FundRaiser community!

We want YOU to join our Jimmy FundRaiser community! The Dana-Farber Community Fundraising Event (CFE) program is where community members hold their own fundraisers or events on behalf of Dana-Farber and the Jimmy Fund. Fundraisers range from bake sales to hiking mountains, walking a 5k, and holding a virtual cooking class. Holding a fundraiser can be an outlet for individuals or families who want to take an “action” towards supporting a loved one, remembering a loved one, or fighting their own fight against cancer.

Read more..

Zachary Hunter - 20 Years at Dana-Farber!

Zachary Hunter - 20 Years at Dana-Farber!

I first met Zach in 2004 when I joined the Bing Center as a volunteer. He was managing clinical trials, and immediately became my "go-to" person when I needed help or advice on any technical issue. Zach created the first WM Workshop website, and then taught me how to maintain it. I was able to build on that knowledge to create other websites.

Read more..

What insights can multi-omics provide into the mechanism of disease progression in WM?

What insights can multi-omics provide into the mechanism of disease progression in WM?

On behalf of the International Waldenstrom's Macroglobulinemia Foundation (IWMF), the Lymphoma Hub was pleased to speak with Zachary Hunter, Dana-Farber Cancer Institute, Boston, US. We asked, What insights can multi-omics provide into the mechanism of disease progression in Waldenstrom’s macroglobulinemia (WM)?

Read more..